Sara
Labiano Almiñana
Investigadora
Publicaciones (44) Publicaciones de Sara Labiano Almiñana
2024
-
Characterization of immune populations in the tumor microenvironment of diffuse midline glioma orthotopic mouse models by flow cytometry
STAR Protocols, Vol. 5, Núm. 1
-
Combination of locoregional radiotherapy with a TIM-3 aptamer improves survival in diffuse midline glioma models
JCI Insight, Vol. 9, Núm. 18
-
Radiotherapy protocols for mouse cancer model
Methods in Cell Biology (Academic Press Inc.), pp. 99-113
-
The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma models
Neuro-Oncology, Vol. 26, Núm. 8, pp. 1509-1525
2023
-
Flow cytometry-assisted quantification of immune cells infiltrating irradiated tumors in mice
Methods in Cell Biology, Vol. 174, pp. 1-16
-
TIM-3 blockade in diffuse intrinsic pontine glioma models promotes tumor regression and antitumor immune memory
Cancer Cell, Vol. 41, Núm. 11, pp. 1911-1926.e8
2022
-
Assessment of hypoxia by pimonidazole staining following radiotherapy
Methods in Cell Biology (Academic Press Inc.), pp. 179-189
-
Editorial: The Impact of Angiogenic Growth Factors and Hypoxia on the Antitumor Immune Response
Frontiers in Immunology
-
Exploiting 4-1BB immune checkpoint to enhance the efficacy of oncolytic virotherapy for diffuse intrinsic pontine gliomas
JCI Insight, Vol. 7, Núm. 7
-
Galectin-3 inhibition boosts the therapeutic efficacy of Semliki Forest virus in pediatric osteosarcoma
Molecular Therapy - Oncolytics, Vol. 26, pp. 246-264
-
Local Treatment of a Pediatric Osteosarcoma Model with a 4-1BBL Armed Oncolytic Adenovirus Results in an Antitumor Effect and Leads to Immune Memory
Molecular Cancer Therapeutics, Vol. 21, Núm. 3, pp. 471-480
-
Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma
New England Journal of Medicine, Vol. 386, Núm. 26, pp. 2471-2481
2021
-
CD137 and PD-L1 targeting with immunovirotherapy induces a potent and durable antitumor immune response in glioblastoma models
Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 7
-
CD40 agonist targeted to fibroblast activation protein a synergizes with radiotherapy in murine HPV-positive head and neck tumors
Clinical Cancer Research, Vol. 27, Núm. 14, pp. 4054-4065
-
Delta-24-RGD, an oncolytic adenovirus, increases survival and promotes proinflammatory immune landscape remodeling in models of AT/RT and CNS-PNET
Clinical Cancer Research, Vol. 27, Núm. 6, pp. 1807-1820
-
Erratum: CD137 and PD-L1 targeting with immunovirotherapy induces a potent and durable antitumor immune response in glioblastoma models (Journal for ImmunoTherapy of Cancer (2021) 9 (e002644) DOI: 10.1136/jitc-2021-002644)
Journal for ImmunoTherapy of Cancer
-
Fibroblast activation protein a-targeted CD40 agonism abrogates systemic toxicity and enables administration of high doses to induce effective antitumor immunity
Clinical Cancer Research, Vol. 27, Núm. 14, pp. 4036-4053
-
Local administration of IL-12 with an HC vector results in local and metastatic tumor control in pediatric osteosarcoma
Molecular Therapy - Oncolytics, Vol. 20, pp. 23-33
2020
-
Enhanced Phenotype Definition for Precision Isolation of Precursor Exhausted Tumor-Infiltrating CD8 T Cells
Frontiers in Immunology, Vol. 11
2019
-
Intratumor Adoptive Transfer of IL-12 mRNA Transiently Engineered Antitumor CD8+ T Cells
Cancer cell, Vol. 36, Núm. 6, pp. 613-629